Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertuzumab Extension Study in Solid Cancers
NCT00096941Phase 2Completed
- Sponsor
- Genentech
- Start
- May 2005
- Primary completion
- Oct 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of pertuzumab in solid tumor, sponsored by Genentech. Started May 2005; status: completed.
02
Drugs
pertuzumab
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00096941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096941.